Print

Biothera to Present Research Results at European Society for Medical Oncology World Gastrointestinal Congress  
4/19/2011 10:16:17 AM

EAGAN, Minn.--(BUSINESS WIRE)--Biothera has been accepted to present data from its Phase II clinical trial in stage IV KRAS-mutant colorectal cancer at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer June 22-25 in Barcelona, Spain.
//-->